Literature DB >> 26105162

[Influence of lifestyle on neurodegenerative diseases].

J B Schulz1, G Deuschl.   

Abstract

Lifestyle factors in midlife have an important influence on the risk of developing a neurodegenerative disease during later life. Data on lifestyle factors exist for Alzheimer's disease and Parkinson's disease. Continuous physical and cognitive activity, a balanced or Mediterranean diet with a high proportion of unsaturated fatty acids, the pharmacological treatment of arterial hypertension, sufficient and unfragmented sleep and possibly treatment with lipophilic statins reduce the risk of developing dementia later in life. Several studies in recent years have provided evidence that during the last decades the age-adjusted incidence of dementia has decreased. This is probably due to a healthier lifestyle and the treatment of risk factors. Continuous physical activity also decreases the likelihood of developing Parkinson's disease. Whether lifestyle factors also have an influence on the course and the progression of Alzheimer's and Parkinson's diseases in the symptomatic stages is unknown.

Entities:  

Mesh:

Year:  2015        PMID: 26105162     DOI: 10.1007/s00115-014-4252-y

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  27 in total

1.  Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26-week randomized, placebo-controlled, double-blind trial.

Authors:  Mikael Simons; Frank Schwärzler; Dieter Lütjohann; Klaus von Bergmann; Konrad Beyreuther; Johannes Dichgans; Henning Wormstall; Tobias Hartmann; Jörg B Schulz
Journal:  Ann Neurol       Date:  2002-09       Impact factor: 10.422

Review 2.  Systematic review: factors associated with risk for and possible prevention of cognitive decline in later life.

Authors:  Brenda L Plassman; John W Williams; James R Burke; Tracey Holsinger; Sophiya Benjamin
Journal:  Ann Intern Med       Date:  2010-06-14       Impact factor: 25.391

3.  Statin therapy is associated with reduced neuropathologic changes of Alzheimer disease.

Authors:  G Li; E B Larson; J A Sonnen; J B Shofer; E C Petrie; A Schantz; E R Peskind; M A Raskind; J C S Breitner; T J Montine
Journal:  Neurology       Date:  2007-08-28       Impact factor: 9.910

4.  Physical activity and risk of Parkinson's disease in the Swedish National March Cohort.

Authors:  Fei Yang; Ylva Trolle Lagerros; Rino Bellocco; Hans-Olov Adami; Fang Fang; Nancy L Pedersen; Karin Wirdefeldt
Journal:  Brain       Date:  2014-11-18       Impact factor: 13.501

5.  A change in sleep pattern may predict Alzheimer disease.

Authors:  Elizabeth A Hahn; Hui-Xin Wang; Ross Andel; Laura Fratiglioni
Journal:  Am J Geriatr Psychiatry       Date:  2013-08-14       Impact factor: 4.105

6.  Statins and the risk of dementia.

Authors:  H Jick; G L Zornberg; S S Jick; S Seshadri; D A Drachman
Journal:  Lancet       Date:  2000-11-11       Impact factor: 79.321

7.  Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade.

Authors:  Clifford R Jack; David S Knopman; William J Jagust; Leslie M Shaw; Paul S Aisen; Michael W Weiner; Ronald C Petersen; John Q Trojanowski
Journal:  Lancet Neurol       Date:  2010-01       Impact factor: 44.182

8.  Antihypertensive drugs decrease risk of Alzheimer disease: Ginkgo Evaluation of Memory Study.

Authors:  Sevil Yasar; Jin Xia; Wenliang Yao; Curt D Furberg; Qian-Li Xue; Carla I Mercado; Annette L Fitzpatrick; Linda P Fried; Claudia H Kawas; Kaycee M Sink; Jeff D Williamson; Steven T DeKosky; Michelle C Carlson
Journal:  Neurology       Date:  2013-08-02       Impact factor: 9.910

9.  Midlife and late-life body mass index and late-life dementia: results from a prospective population-based cohort.

Authors:  Anna-Maija Tolppanen; Tiia Ngandu; Ingemar Kåreholt; Tiina Laatikainen; Minna Rusanen; Hilkka Soininen; Miia Kivipelto
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

Review 10.  Long-term health benefits of physical activity--a systematic review of longitudinal studies.

Authors:  Miriam Reiner; Christina Niermann; Darko Jekauc; Alexander Woll
Journal:  BMC Public Health       Date:  2013-09-08       Impact factor: 3.295

View more
  3 in total

Review 1.  Gauging the role and impact of drug interactions and repurposing in neurodegenerative disorders.

Authors:  Dharmendra Kumar Khatri; Amey Kadbhane; Monica Patel; Shweta Nene; Srividya Atmakuri; Saurabh Srivastava; Shashi Bala Singh
Journal:  Curr Res Pharmacol Drug Discov       Date:  2021-04-08

2.  Drinking water temperature affects cognitive function and progression of Alzheimer's disease in a mouse model.

Authors:  Jiang-Ping Wei; Wen Wen; Yuan Dai; Li-Xia Qin; Yue-Qiang Wen; Dayue Darrel Duan; Shi-Jun Xu
Journal:  Acta Pharmacol Sin       Date:  2020-05-25       Impact factor: 6.150

Review 3.  Lifestyle and neurodegeneration in midlife as expressed on functional magnetic resonance imaging: A systematic review.

Authors:  Hinesh Topiwala; Graciela Muniz Terrera; Lucy Stirland; Kathryn Saunderson; Tom C Russ; Marshall F Dozier; Craig W Ritchie
Journal:  Alzheimers Dement (N Y)       Date:  2018-05-03
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.